Narnolia

Narnolia

Toll Free No: 1800-103-7212

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE559.80-2.25 (-0.4 %)
PREV CLOSE ( ) 562.05
OPEN PRICE ( ) 562.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 559.80 (202)
VOLUME 71791
TODAY'S LOW / HIGH ( )553.85 565.70
52 WK LOW / HIGH ( )483.75 678
NSE558.55-3.15 (-0.56 %)
PREV CLOSE( ) 561.70
OPEN PRICE ( ) 561.40
BID PRICE (QTY) 558.55 (1204)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1896565
TODAY'S LOW / HIGH( ) 553.20 564.50
52 WK LOW / HIGH ( )483.75 678.45
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 17-08 1935
Management Info
Y K Hamied - Chairman Umang Vohra - Managing Director
Registered Office

Address Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower Parel,
Mumbai,
Maharashtra-400013

Phone 022-24826000 / 022-24826951

Email cosecretary@cipla.com

Website www.cipla.com

Registrars Details
Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX
NEWS
17Apr Cipla’s arm to acquire 30% stake in Br
Cipla’s South Africa-based subsidiary--- Cipla Medpro will acquire 30 pe..
16Apr Dr. Reddys Lab, Majesco and Cipla to s
Dr. Reddys Laboratories has received the Establishment Inspection Report..
16Apr Cipla’s arm inks definitive agreement
Cipla’s subsidiary -- Cipla Technologies LLC and Pulmatrix, Inc., a clin..
16Apr Cipla rises with its arm inking defini
Cipla is currently trading at Rs. 566.75, up by 0.65 points or 0.11% fro..
12Apr Cipla launches Niveoli HFA inhaler for
Cipla has launched Niveoli, India’s first extra-fine particle beclometha..
Financials
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit2953.214685.2
Gross Profit 4115.1 19114
Operating Profit 5630.325304.3
Net Sales 28352114448.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
peergroup  7833.20 (0.70%)
M.Cap ( in Cr)16645.00
Divis Lab (BSE)
peergroup  1740.60 (3.03%)
M.Cap ( in Cr)46207.46
Piramal Enterprises (BSE)
peergroup  2585.70 (1.96%)
M.Cap ( in Cr)47838.73
Dr. Reddys Lab (BSE)
peergroup  2855.35 (1.38%)
M.Cap ( in Cr)47417.64
Astrazeneca Pharma I (BSE)
peergroup  2252.50 (1.22%)
M.Cap ( in Cr)5631.25
Shareholding Pattern
PROMOTERS 36.7%
FI/BANKS/INSURANCE 3.75%
NON-INSTITUTION 22.49%
MUTUAL FUNDS/UTI 10.27%
FII 0.67%
GOVERNMENT 0%
About Cipla Ltd.

Cipla Ltd. was incorporated in the year 17-08-1935. Its today's share price is 562.05. Its current market capitalisation stands at Rs 45103.27 Cr. In the latest quarter, company has reported Gross Sales of Rs. 152192.5 Cr and Total Income of Rs.155133.6 Cr. The company's management includes Rajendra Chopra, Peter Lankau, Naina Lal Kidwai, Punita Lal, Adil Zainulbhai, Peter Mugyenyi, Ashok Sinha, S Radhakrishnan, Umang Vohra, Samina Vaziralli, MK Hamied, Y K Hamied.

It is listed on the BSE with a BSE Code of 500087 , NSE with an NSE Symbol of CIPLA and ISIN of INE059A01026. It's Registered office is at Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower ParelMumbai-400013, Maharashtra. Their Registrars are ACC Ltd. It's auditors are RGN Price & Co, RS Bharucha & Co, V Sankar Aiyar & Co, Walker Chandiok & Co LLP

Directory

Narnolia Research & Advisory Narnolia Trading Platforms Narnolia Online | media Room